<Now,as I SLOWLY study options,I ask a stupid question--just noted
that the volume on June22.5 puts on DHI on friday was 20contracts,but
the Open Interest is listed as 0(zero)--now my STUPID question is,"How
can you have a volume of 20 contracts and end up with 0 open interest?>
Volume does not reflect if the trade was to open or close a position.
<Regards BJCT I am going to hold off until I learn more about the new
Strategic Plan--this whole shift to Elan and Hoffman-Larouche of which I really
have no understanding of--O'Shea is obviously redirecting the company.
And I do remain cautious until I understand why Paramount Capital was dumping shares--the assumption that is simply profit taking is a real possibility--but not sure.>
I'm also not sure about BJCT. I posted my questions and have not found answers. It remains an interesting and timely stock, but I am not ready to buy.
<Am still,for now,going to hold ORVX,in spite of the semi-floorless
CPs,as on runnung a search today found 21 articles published by Oravax
scientist on behalf of Oravax in scientific journals--they have quite
a few 1st rate scientist in their employ--and the special situation
of their VP I just can't walk away from--so will see.>
ORVX is too risky for the Amigos.
<O yes,one more question--Antex biologicals,what's the latest about
a reverse split--and could they then get on to NSDQ--as that could
really move that stock,don't you think?>
The reverse split is going to be decided upon at the annual meeting this month. I personally think that it's the best thing that could happen to ANTEX, although there is generally a negative connotation to reverse splits. ANTEX qualifies for a Nasdaq listing except for stock share price.
Sergio |
